MT 4 McNEIL (Pancreaze 17,500 U amylase / 4,200 U lipase / 10,000 U protease)

Generic Name: pancrelipase

Pill imprint MT 4 McNEIL has been identified as Pancreaze 17,500 U amylase / 4,200 U lipase / 10,000 U protease.

Pancreaze is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Pancreaze 17,500 U amylase / 4,200 U lipase / 10,000 U protease is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for MT 4 McNEIL

Pancreaze
Generic Name:
pancrelipase
Imprint:
MT 4
McNEIL
Strength:
17,500 U amylase / 4,200 U lipase / 10,000 U protease
Color:
Yellow / Clear
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
National Drug Code (NDC):
50458-0341
Inactive Ingredients:
microcrystalline cellulose
crospovidone
silicon dioxide
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
triethyl citrate
magnesium silicate
dimethicone
gelatin
titanium dioxide
sodium lauryl sulfate
sorbitan monolaurate
ferric oxide yellow

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)